Skip to content

A clinical trial to compare the effects of two Ayurvedic treatments in patients with Varicose veins

An Open label randomised clinical study to compare the efficacy of Siravyadha and Jaloukavacarana in Varicose veins

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018274
Enrollment
100
Registered
2019-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I83- Varicose veins of lower extremities

Interventions

Intervention1: Siravyadha: 60-100ml blood letting 4 sittings at an interval of 15 days Control Intervention1: Jaloukavacharana: 20-40ml blood letting 4 sittings at an interval of 15 days

Sponsors

Dr Suresh P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 25 to 65 years Irrespective of sex Patients with classical symptoms of Varicose vein Grade1, 2 and 3 Patients with varicose vein in Lower limb only

Exclusion criteria

Exclusion criteria: Varicosity associated with complications like deep vein thrombosis,calcification,equinus deformity,venous ulcer, thrombophlebitis Patients having other systemic pathology( TB,DM,HIV/AIDS,HBsAg+ve &VDRL) Patients of varicose vein Grade4,5,6 Patients with bleeding disorders

Design outcomes

Primary

MeasureTime frame
Reduction in subjective and objective symptomsTimepoint: Intervention for 4 sittings at an interval of 15 days Assessment done on Day15, Day30 Day45, Day60 Follow up on 60th day after treatment

Secondary

MeasureTime frame
Reduction in tenderness, pain, itching,Tortuosity,Odema and discolourationTimepoint: Intervention for 4 sittings at an interval of 15 days. Assessment done on Day15, Day30,Day45,Day 60 Followup on 60th day after treatment

Countries

India

Contacts

Public ContactDr Ratnaprava Mishra

Mandsaur Institute of Ayurved Education & Research

dr.rpmishra@gmail.com8281931485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026